--- title: The GLG Pharma STAT Blog description: A blog about STAT 3 and cancer. GLG Pharma, LLC a cancer treatment company. --- # The GLG Pharma STAT Blog ## [STAT3, Cancer and Genetics - GLG Pharma](https://www.glgpharma.com/glg-pharma-stat-blog/glg-pharma-stat-blog/bid/77688/stat3-cancer-and-genetics-glg-pharma) ## [GLG Pharma STAT 3 Blog](https://www.glgpharma.com/glg-pharma-stat-blog/glg-pharma-stat-blog/bid/42376/glg-pharma-stat-3-blog) ## [GLG Pharma Announces Presentation at Upcoming AACR, the Annual Cancer Research Meeting 2015 April 18-22, 2015](https://www.glgpharma.com/glg-pharma-stat-blog/blog/-temporary-slug-75f1ab45-af3b-4921-b113-83e29ae6d923) ## [GLG Pharma at Rare Disease Day Tallahassee Florida!](https://www.glgpharma.com/glg-pharma-stat-blog/blog/glg-pharma-at-rare-disease-day-tallahassee-florida) ## [Why Work on Treatment or Cures for Rare Diseases?](https://www.glgpharma.com/glg-pharma-STAT-blog/bid/114027/Why-Work-on-Treatment-or-Cures-for-Rare-Diseases?hsLang=en-us) ## [WIIFM?](https://www.glgpharma.com/glg-pharma-STAT-blog/bid/113921/WIIFM?hsLang=en-us) ## [SEC Reviews Accredited Investor Requirements](https://www.glgpharma.com/glg-pharma-STAT-blog/bid/113915/SEC-Reviews-Accredited-Investor-Requirements?hsLang=en-us) ## [Why Invest in Early Stage Drug Development for Rare Diseases?](https://www.glgpharma.com/glg-pharma-STAT-blog/bid/113774/Why-Invest-in-Early-Stage-Drug-Development-for-Rare-Diseases?hsLang=en-us) ## [GLG Pharma Attending Faster Cures Partnering Nov. 16-18 NYC](https://www.glgpharma.com/glg-pharma-STAT-blog/bid/113660/GLG-Pharma-Attending-Faster-Cures-Partnering-Nov-16-18-NYC?hsLang=en-us) ## [The Alpha-1 Antitrypsin Deficiency Walk!](https://www.glgpharma.com/glg-pharma-STAT-blog/bid/113621/The-Alpha-1-Antitrypsin-Deficiency-Walk?hsLang=en-us) ## [Why are STAT3 Inhibitors Important in Cancer Therapy?](https://www.glgpharma.com/glg-pharma-STAT-blog/bid/113364/Why-are-STAT3-Inhibitors-Important-in-Cancer-Therapy?hsLang=en-us) ## [Who is Your Patient Advocate? ](https://www.glgpharma.com/glg-pharma-STAT-blog/bid/111043/Who-is-Your-Patient-Advocate?hsLang=en-us) ## [The Entrepreneur's Real Valley of Death](https://www.glgpharma.com/glg-pharma-STAT-blog/bid/109890/The-Entrepreneur-s-Real-Valley-of-Death?hsLang=en-us) ## [The New Way to Fund Biotech/Pharma/Lifescience Startups?](https://www.glgpharma.com/glg-pharma-STAT-blog/bid/109181/The-New-Way-to-Fund-Biotech-Pharma-Lifescience-Startups?hsLang=en-us) ## [Funding News! CB Insights 'The Bull is in Full Swing'!](https://www.glgpharma.com/glg-pharma-STAT-blog/bid/109072/Funding-News-CB-Insights-The-Bull-is-in-Full-Swing?hsLang=en-us) ## [GLG Focused on Polycystic Kidney Disease and Alpha-1 Tryptase and HCC](https://www.glgpharma.com/glg-pharma-STAT-blog/bid/108607/GLG-Focused-on-Polycystic-Kidney-Disease-and-Alpha-1-Tryptase-and-HCC?hsLang=en-us) ## [Why is GLG Pharma Different?](https://www.glgpharma.com/glg-pharma-STAT-blog/bid/103415/Why-is-GLG-Pharma-Different?hsLang=en-us) ## [GLG-302 Selected by NCI for Funding in Cancer Prevent Program](https://www.glgpharma.com/glg-pharma-STAT-blog/bid/99370/GLG-302-Selected-by-NCI-for-Funding-in-Cancer-Prevent-Program?hsLang=en-us) ## [Startup Funds Still Available! Matching Grant for Investment in Cancer Drug Development.](https://www.glgpharma.com/glg-pharma-STAT-blog/bid/85912/Startup-Funds-Still-Available-Matching-Grant-for-Investment-in-Cancer-Drug-Development?hsLang=en-us) [All posts](https://www.glgpharma.com/glg-pharma-stat-blog/all) *STAT 3 publications are numerous and we hope that the following links will help you better understand it's importance in cancer cell metabolism and cancer cell death. Inhibiting STAT 3 is an important mechanism for encouraging cancer cell death. Using STAT 3 inhibitors with other traditional cancer chemotherapy should help improve patient outcomes. Linking a diagnostic with a STAT 3 inhibitor will also help reduce patient side effects as well as potentially improve patient outcomes.* ### Latest Posts ### Browse by Tag - [accredited investor (2)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/accredited-investor) - [accredited investors (2)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/accredited-investors) - [Alpha-1 (5)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/alpha-1) - [Alpha-1 Antitry (2)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/alpha-1-antitry) - [Alpha-1 Antitrypsin deficiency (1)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/alpha-1-antitrypsin-deficiency) - [angel investor (2)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/angel-investor) - [angel investors (2)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/angel-investors) - [Cancer (8)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/cancer) - [cancer diagnosis (6)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/cancer-diagnosis) - [cancer prevention (3)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/cancer-prevention) - [Cancer Stem Cells (3)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/cancer-stem-cells) - [Cancer Therapy (3)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/cancer-therapy) - [Chemotherapy (2)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/chemotherapy) - [GLG (2)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/glg) - [GLG Pharma (13)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/glg-pharma) - [jobs act (1)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/jobs-act) - [PKD (2)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/pkd) - [Polycystic Kidney Disease (3)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/polycystic-kidney-disease) - [Rare Disease (1)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/rare-disease) - [Rare Diseases (3)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/rare-diseases) - [sec (1)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/sec) - [STAT (6)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/stat) - [STAT 3 inhibitors (6)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/stat-3-inhibitors) - [STAT3 (15)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/stat3) - [STAT3 cancer (7)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/stat3-cancer) - [STAT3 inhibitors (11)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/stat3-inhibitors) - [STAT3 mechanism (1)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/stat3-mechanism) - [WIIFM (1)](https://www.glgpharma.com/glg-pharma-stat-blog/topic/wiifm) ### Links **[Mayo Clinic](http://www.mayoclinic.com/)** **[Moffitt Cancer Center](http://www.moffitt.org/)** **[Dana-Farber](http://www.dana-farber.org/)** ### Connect With Us